Meet Inspiration Biopharmaceuticals
At Inspiration, we have made it our personal mission to improve available treatment options for all people with hemophilia worldwide. The founding families of our company have been intimately impacted by hemophilia, as both families have sons who have hemophilia.
We understand how crucial the need is for more treatment options. Hemophilia treatment has come a long way in the past few decades, but we still have a long way to go. It is estimated that across the globe, only about a quarter of the approximately 400,000 people with hemophilia receive the treatment they need.1
One of our main goals is to broaden access to hemophilia care worldwide. We are working to develop recombinant products that will positively impact the lives of people living with hemophilia everywhere. In many countries, we plan to provide the first recombinant factor IX (rFIX) and offer more access that might not otherwise be available. In other countries, we plan to offer another choice in treatment that may allow greater access to prophylaxis for people with hemophilia.
Our other main goal is to improve treatment options for people with inhibitor complications. We recognize that there is a great need to improve efficacy and options for people with problematic inhibitors.2
The mission of our founding families, to change the experience of living with hemophilia, is the force behind our business and perspective. We recruited experts with experience in coagulation and hemostasis, all of whom have a strong drive to improve hemophilia treatment, to manage our company. With a unique depth of experience and a clear vision, together we hope to accelerate the advancement of hemophilia treatment and steer it toward our future goal—life less affected by hemophilia.
To further our commitment to the hemophilia community, we have partnered with Ipsen to bring our product portfolio to individuals with hemophilia in Europe. Like Inspiration, Ipsen is a family-owned company committed to and passionate about patient care. As a leader in specialty healthcare, Ipsen has a long-standing history in therapeutics, particularly in debilitating diseases. Both Inspiration and Ipsen are focused on broadening global access to safe and effective recombinant therapies and advancing innovative solutions for people living with this disease. Together we hope to reach our shared goal of making hemophilia more manageable for everyone, everywhere.